Diverse Effects on the Native β-sheet of the Human Prion Protein Due to Disease-associated Mutations

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2010 Oct 19

PMID 20949975

Citations 15

Authors

Wei Chen

Marc W van der Kamp

Valerie Daggett

Affiliations

Soon will be listed here.

Abstract

Prion diseases are fatal neurodegenerative disorders that involve the conversion of the normal cellular form of the prion protein (PrP(C)) to a misfolded pathogenic form (PrP(Sc)). There are many genetic mutations of PrP associated with human prion diseases. Three of these point mutations are located at the first strand of the native β-sheet in human PrP: G131V, S132I, and A133V. To understand the underlying structural and dynamic effects of these disease-causing mutations on the human PrP, we performed molecular dynamics of wild-type and mutated human PrP. The results indicate that the mutations induced different effects but they were all related to misfolding of the native β-sheet: G131V caused the elongation of the native β-sheet, A133V disrupted the native β-sheet, and S132I converted the native β-sheet to an α-sheet. The observed changes were due to the reorientation of side chain-side chain interactions upon introducing the mutations. In addition, all mutations impaired a structurally conserved water site at the native β-sheet. Our work suggests various misfolding pathways for human PrP in response to mutation.

Citing Articles

Detecting early stage structural changes in wild type, pathogenic and non-pathogenic prion variants using Markov state model.

Jani V, Sonavane U, Joshi R RSC Adv. 2022; 9(25):14567-14579.

PMID: 35519320 PMC: 9064127. DOI: 10.1039/c9ra01507h.

Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure.

Bromley D, Daggett V Protein Sci. 2020; 29(9):1983-1999.

PMID: 32715544 PMC: 7454552. DOI: 10.1002/pro.3921.

Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Zheng Z, Zhang M, Wang Y, Ma R, Guo C, Feng L Sci Rep. 2018; 8(1):13211.

PMID: 30181558 PMC: 6123418. DOI: 10.1038/s41598-018-31394-6.

Exploration of the Main Sites for the Transformation of Normal Prion Protein (PrP) into Pathogenic Prion Protein (PrP).

Liu X, Feng X, Wang G, Gong B, Ahmad W, Liu N J Vet Res. 2018; 61(1):11-22.

PMID: 29978050 PMC: 5894410. DOI: 10.1515/jvetres-2017-0002.

Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Cheng C, Koldso H, van der Kamp M, Schiott B, Daggett V J Neurochem. 2017; 142(1):171-182.

PMID: 28407243 PMC: 5500178. DOI: 10.1111/jnc.14044.

References

Chebaro Y, Derreumaux P . The conversion of helix H2 to beta-sheet is accelerated in the monomer and dimer of the prion protein upon T183A mutation. J Phys Chem B. 2009; 113(19):6942-8. DOI: 10.1021/jp900334s. View

van der Kamp M, Daggett V . Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol. 2010; 404(4):732-48. PMC: 2994014. DOI: 10.1016/j.jmb.2010.09.060. View

van der Kamp M, Daggett V . The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel. 2009; 22(8):461-8. PMC: 2719504. DOI: 10.1093/protein/gzp039. View

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

De Simone A, Dodson G, Verma C, Zagari A, Fraternali F . Prion and water: tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci U S A. 2005; 102(21):7535-40. PMC: 1140432. DOI: 10.1073/pnas.0501748102. View

Scouras A, Daggett V . The Dynameomics rotamer library: amino acid side chain conformations and dynamics from comprehensive molecular dynamics simulations in water. Protein Sci. 2011; 20(2):341-52. PMC: 3048419. DOI: 10.1002/pro.565. View

Aguzzi A, Calella A . Prions: protein aggregation and infectious diseases. Physiol Rev. 2009; 89(4):1105-52. DOI: 10.1152/physrev.00006.2009. View

Armen R, Alonso D, Daggett V . Anatomy of an amyloidogenic intermediate: conversion of beta-sheet to alpha-sheet structure in transthyretin at acidic pH. Structure. 2004; 12(10):1847-63. DOI: 10.1016/j.str.2004.08.005. View

Aguzzi A, Baumann F, Bremer J . The prion's elusive reason for being. Annu Rev Neurosci. 2008; 31:439-77. DOI: 10.1146/annurev.neuro.31.060407.125620. View

10.

Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F . NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A. 2000; 97(1):145-50. PMC: 26630. DOI: 10.1073/pnas.97.1.145. View

11.

Viles J, Donne D, Kroon G, Prusiner S, Cohen F, Dyson H . Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics. Biochemistry. 2001; 40(9):2743-53. DOI: 10.1021/bi002898a. View

12.

Cordier F, Nisius L, Dingley A, Grzesiek S . Direct detection of N-H[...]O=C hydrogen bonds in biomolecules by NMR spectroscopy. Nat Protoc. 2008; 3(2):235-41. DOI: 10.1038/nprot.2007.498. View

13.

DeMarco M, Daggett V . Molecular mechanism for low pH triggered misfolding of the human prion protein. Biochemistry. 2007; 46(11):3045-54. DOI: 10.1021/bi0619066. View

14.

Beck D, Daggett V . Methods for molecular dynamics simulations of protein folding/unfolding in solution. Methods. 2004; 34(1):112-20. DOI: 10.1016/j.ymeth.2004.03.008. View

15.

Barfield M . Structural dependencies of interresidue scalar coupling (h3)J(NC') and donor (1)H chemical shifts in the hydrogen bonding regions of proteins. J Am Chem Soc. 2002; 124(15):4158-68. DOI: 10.1021/ja012674v. View

16.

Richardson J, Getzoff E, Richardson D . The beta bulge: a common small unit of nonrepetitive protein structure. Proc Natl Acad Sci U S A. 1978; 75(6):2574-8. PMC: 392604. DOI: 10.1073/pnas.75.6.2574. View

17.

Armen R, DeMarco M, Alonso D, Daggett V . Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci U S A. 2004; 101(32):11622-7. PMC: 511030. DOI: 10.1073/pnas.0401781101. View

18.

Armen R, Daggett V . Characterization of two distinct beta2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology. Biochemistry. 2005; 44(49):16098-107. DOI: 10.1021/bi050731h. View

19.

Lee S, Antony L, Hartmann R, Knaus K, Surewicz K, Surewicz W . Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J. 2009; 29(1):251-62. PMC: 2808380. DOI: 10.1038/emboj.2009.333. View

20.

Armen R, Bernard B, Day R, Alonso D, Daggett V . Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases. Proc Natl Acad Sci U S A. 2005; 102(38):13433-8. PMC: 1224618. DOI: 10.1073/pnas.0502068102. View